Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.

Rupesh Manam; Jasmine L Martin; Joshua A Gross; Dhishna Chaudhary; Sajeel Chowdhary; Patricio S Espinosa; Edgardo S Santos

doi:10.7759/CUREUS.3371

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.

Rupesh Manam, Jasmine L Martin, Joshua A Gross, Dhishna Chaudhary, Sajeel Chowdhary, Patricio S Espinosa, Edgardo S Santos

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cureus
Volume	10
DOIs	https://doi.org/10.7759/CUREUS.3371
State	Published - Sep 27 2018

Disciplines

Immunology and Infectious Disease
Medicine and Health Sciences

Access to Document

10.7759/CUREUS.3371License: Unspecified

Cite this

@article{a4932b7ff73b4fcdb8f51eaba34230bf,

title = "Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.",

author = "Rupesh Manam and Martin, \{Jasmine L\} and Gross, \{Joshua A\} and Dhishna Chaudhary and Sajeel Chowdhary and Espinosa, \{Patricio S\} and Santos, \{Edgardo S\}",

note = "Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use. The immune-related adverse ...",

year = "2018",

month = sep,

day = "27",

doi = "10.7759/CUREUS.3371",

language = "American English",

volume = "10",

journal = "Cureus",

}

TY - JOUR

T1 - Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.

AU - Manam, Rupesh

AU - Martin, Jasmine L

AU - Gross, Joshua A

AU - Chaudhary, Dhishna

AU - Chowdhary, Sajeel

AU - Espinosa, Patricio S

AU - Santos, Edgardo S

N1 - Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use. The immune-related adverse ...

PY - 2018/9/27

Y1 - 2018/9/27

UR - https://pubmed.ncbi.nlm.nih.gov/30510881/

U2 - 10.7759/CUREUS.3371

DO - 10.7759/CUREUS.3371

M3 - Article

VL - 10

JO - Cureus

JF - Cureus

ER -

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy.

Disciplines

Access to Document

Other files and links

Cite this